Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn’s Disease: a Prospective Study Based on Clinical Risk Stratification
Jeanine Arkenbosch(Erasmus MC), Annemarie C. de Vries(Erasmus MC), Fiona D M van Schaik(University Medical Center Utrecht), Mariëlle Romberg‐Camps(Zuyderland Medisch Centrum), Sander van der Marel(Medisch Centrum Haaglanden), Evelien Beelen(Erasmus MC), Nicole S. Erler(Erasmus MC), Frank Hoentjen(Radboud University Nijmegen), Gürsah Kats‐Ugurlu(University Medical Center Groningen), Sita Jansen(Reinier de Graaf Hospital), Carmen S. Horjus(Rijnstate Hospital), Marijn C. Visschedijk(University Medical Center Groningen), Alfred Janssen(Zuyderland Medisch Centrum), Gerard Dijkstra(University Medical Center Groningen), Bindia Jharap(Meander Medisch Centrum), Marjolijn Duijvestein(Amsterdam University Medical Centers), C. Janneke van der Woude(Radboud University Nijmegen), Jeroen Maljaars(Leiden University Medical Center), Rachel West(Sint Franciscus Gasthuis), Laurents P S Stassen(Maastricht University Medical Centre), Michail Doukas(Erasmus MC), Nanne K.H. de Boer, Ariadne H.A.G. Ooms(PathoFinder (Netherlands)), Oddeke van Ruler(IJsselland Ziekenhuis)
Cited by 31
Related Papers
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478
Complex host genetics influence the microbiome in inflammatory bowel disease
|Genome Medicine|2014|431